Skip to main content

Table 4 Association between pathogens and patients’ demographic and clinical characteristics

From: Epidemiology and clinical characteristics of pathogens positive in hospitalized children with segmental/lobar pattern pneumonia

VariablesM.pneumoniaeRSVCPIFAPIVSADVCOXLPIFBS.pneumoniae
N353117314864828
Gender
 male246 (69.69%)10 (90.91%)3 (42.86%)3 (100.00%)10 (71.43%)4 (50.00%)3 (50.00%)2 (50.00%)4 (50.00%)20 (71.43%)
 female107 (30.31%)1 (9.09%)4 (57.14%)0 (0.00%)4 (28.57%)4 (50.00%)3 (50.00%)2 (50.00%)4 (50.00%)8 (28.57%)
Age (years)7.8 ± 4.18.4 ± 3.110.2 ± 2.65.4 ± 3.66.5 ± 5.26.8 ± 4.57.6 ± 3.88.3 ± 5.26.8 ± 3.97.9 ± 3.5
Fever
 yes302 (85.55%)8 (72.73%)5 (71.43%)3 (100.00%)10 (71.43%)7 (87.50%)4 (66.67%)3 (75.00%)6 (75.00%)21 (75.00%)
 no51 (14.45%)3 (27.27%)2 (28.57%)0 (0.00%)4 (28.57%)1 (12.50%)2 (33.33%)1 (25.00%)2 (25.00%)7 (25.00%)
Duration of fever (days)4.9 ± 2.85.7 ± 3.23.5 ± 2.64.3 ± 3.23.8 ± 2.34.5 ± 1.95.6 ± 2.44.1 ± 2.64.7 ± 2.64.5 ± 2.4
Duration of cough (days)10.2 ± 6.28.6 ± 5.813.6 ± 6.510.3 ± 6.911.8 ± 9.38.9 ± 4.310.1 ± 6.88.2 ± 4.39.4 ± 7.611.3 ± 6.4
Gasping
 Yes122 (34.56%)3 (27.27%)0 (0.00%)0 (0.00%)1 (7.14%)2 (25.00%)0 (0.00%)0 (0.00%)0 (0.00%)2 (7.14%)
 No231 (65.44%)8 (72.73%)7 (100.00%)3 (100.00%)13 (92.86%)6 (75.00%)6 (100.00%)4 (100.00%)8 (100.00%)26 (92.86%)
Pulmonary crackles at onset
 yes120 (33.99%)3 (27.27%)2 (28.57%)0 (0.00%)4 (28.57%)2 (25.00%)2 (33.33%)1 (25.00%)3 (37.50%)9 (32.14%)
 no233 (66.01%)8 (72.73%)5 (71.43%)3 (100.00%)10 (71.43%)6 (75.00%)4 (66.67%)3 (75.00%)5 (62.50%)19 (67.86%)
Pleural effusion
 Yes15 (4.25%)2 (18.18%)1 (14.29%)0 (0.00%)1 (7.14%)0 (0.00%)0 (0.00%)0 (0.00%)1 (12.50%)1 (3.70%)
 no340 (96.32%)9 (81.82%)6 (85.71%)3 (100.00%)13 (92.86%)8 (100.00%)6 (100.00%)4 (100.00%)7 (87.50%)27 (96.43%)
Extrapulmonary manifestations
 Yes102 (28.90%)0 (0.00%)0 (0.00%)1 (33.33%)2 (14.29%)1 (12.50%)0 (0.00%)0 (0.00%)1 (12.50%)3 (10.71%)
 Erythematous maculopapular rash20 (5.67%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)2 (7.14%)
 Liver lesion46 (13.03%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)
 Kidney lesion9 (2.55%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)
 Neurological complications79 (22.38%)0 (0.00%)0 (0.00%)1 (33.33%)2 (14.29%)1 (12.50%)0 (0.00%)0 (0.00%)1 (12.50%)1 (3.57%)
 no251 (71.10%)11 (100.00%)7 (100.00%)2 (66.67%)12 (85.71%)7 (87.50%)6 (100.00%)4 (100.00%)7 (87.50%)25 (89.29%)
WBC
 abnormal245 (69.41%)5 (45.45%)4 (57.14%)2 (66.67%)6 (42.86%)5 (62.50%)2 (33.33%)2 (50.00%)4 (50.00%)27 (96.43%)
 normal108 (30.59%)6 (54.55%)3 (42.86%)1 (33.33%)8 (57.14%)3 (37.50%)4 (66.67%)2 (50.00%)4 (50.00%)1 (3.57%)
ESR
 abnormal36 (10.20%)1 (9.09%)2 (28.57%)0 (0.00%)1 (7.14%)1 (12.50%)0 (0.00%)1 (25.00%)2 (25.00%)3 (10.71%)
 normal317 (89.80%)10 (90.91%)5 (71.43%)3 (100.00%)13 (92.86%)7 (87.50%)6 (100.00%)3 (75.00%)6 (75.00%)25 (89.29%)
CRP
 abnormal81 (22.95%)3 (27.27%)2 (28.57%)1 (33.33%)4 (28.57%)3 (37.50%)2 (33.33%)1 (25.00%)3 (37.50%)24 (85.71%)
 normal272 (77.05%)8 (72.73%)5 (71.43%)2 (66.67%)10 (71.43%)5 (62.50%)4 (66.67%)3 (75.00%)5 (62.50%)4 (14.29%)
Duration of hospitalization (days)15.8 ± 4.114.2 ± 4.313.6 ± 5. 812.5 ± 3.614.9 ± 5.215.1 ± 3.713.9 ± 6.214.7 ± 5.114.6 ± 2.415.3 ± 4.4